ArticleOncoscience2014

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor.

Georgia A McCann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.